|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
JPRN |
|
Last refreshed on:
|
17 October 2023 |
|
Main ID: |
JPRN-UMIN000014775 |
|
Date of registration:
|
15/08/2014 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Effect of Ipragliflozin, a new oral hypoglycemic agent, on body composition in patients with diabetes
|
|
Scientific title:
|
Effect of Ipragliflozin, a new oral hypoglycemic agent, on body composition in patients with diabetes - Effect of Ipragliflozin on body composition |
|
Date of first enrolment:
|
2014/08/15 |
|
Target sample size:
|
30 |
|
Recruitment status: |
Complete: follow-up complete |
|
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017180 |
|
Study type:
|
Interventional |
|
Study design:
|
Parallel Randomized
|
|
Phase:
|
Not applicable
|
|
|
Countries of recruitment
|
|
Japan
| | | | | | | |
|
Contacts
|
|
Name:
|
Toshihide Kawai |
|
Address:
|
35 Shinanomachi, Shinjuku-ku, Tokyo
Japan |
|
Telephone:
|
03-3353-1211 |
|
Email:
|
tkawai@keio.jp |
|
Affiliation:
|
Keio University School of Medicine Internal Medicine & Institute for Integrated Sports Medicine |
|
|
Name:
|
Toshihide Kawai |
|
Address:
|
35 Shinanomachi, Shinjuku-ku, Tokyo
Japan |
|
Telephone:
|
03-3353-1211 |
|
Email:
|
tkawai@keio.jp |
|
Affiliation:
|
Keio University School of Medicine Internal Medicine & Institute for Integrated Sports Medicine |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: Contraindication for Ipragliflozin Patients who had been treated with metformin or GLP-1 analogues Pregnant woman
Age minimum:
20years-old
Age maximum:
70years-old
Gender:
Male and Female
|
|
Health Condition(s) or Problem(s) studied
|
|
type 2 diabetes
|
|
Intervention(s)
|
Ipragliflozin
Metformin
|
|
Primary Outcome(s)
|
|
Lean body mass
|
|
Secondary Outcome(s)
|
|
body weight fasting plasma glucose HbA1c free fatty acid (24 fraction)
|
|
Source(s) of Monetary Support
|
|
Keio University School of Medicine, Internal Medicine
|
|
Ethics review
|
Status: YES
Approval date:
Contact:
|
|
Results
|
|
Results available:
|
Yes |
|
Date Posted:
|
|
|
Date Completed:
|
27/03/2017 |
|
URL:
|
|
|
|